S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.
about
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applicationsThe role of sphingosine-1-phosphate in endothelial barrier functionAtheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)S1P control of endothelial integritySphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progressGlucose induces sensitivity to oxygen deprivation and modulates insulin/IGF-1 signaling and lipid biosynthesis in Caenorhabditis elegans.Lipoprotein X Causes Renal Disease in LCAT DeficiencyGlucose or Altered Ceramide Biosynthesis Mediate Oxygen Deprivation Sensitivity Through Novel Pathways Revealed by Transcriptome Analysis in Caenorhabditis elegans.Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration.Sources, metabolism, and regulation of circulating sphingosine-1-phosphatePlasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles.Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosisEndothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload.Why targeting HDL should work as a therapeutic tool, but has not.Unraveling the complexities of the HDL lipidomeHDL-C: clinical equipoise and vascular endothelial function.Sphingosine-1-Phosphate Signaling in Endothelial Disorders.Resveratrol exerts a biphasic effect on apolipoprotein M.Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System.LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate.Familial hypercholesterolaemia: cholesterol efflux and coronary disease.Sphingosine-1-Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+ Sensitivity and Na+/H+ Exchange and Mediates Protection by Ischemic Preconditioning.Plasma sphingolipids and depressive symptoms in coronary artery disease.Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate.Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: Spotlight on sphingosine-1-phosphate/serum amyloid A ratio.Calcitriol concomitantly enhances insulin sensitivity and alters myocellular lipid partitioning in high fat-treated skeletal muscle cells.Molecular Regulation of Sprouting Angiogenesis.
P2860
Q26779667-5CE7C4EA-3E82-4288-980B-C9BE985327AFQ26862336-B577F668-CF32-43E4-A206-DC96F14E9E42Q27000801-EB67ABE7-ABE0-4022-8379-46030B38B685Q27000974-19327D75-BC1D-4C47-848D-DA3BBF0CE5DDQ27001065-D24C4165-ED3D-427A-BDC3-DC866E70BBE1Q27346465-82C26F87-9C11-42C6-95E8-AEAAD2691AADQ28550403-B79163C8-2334-4261-9C99-A845F336DEF5Q30823934-71E6EDBE-10A7-45C7-8298-F3D4685ACDC0Q33405952-D948BE8D-3857-4B96-9CC8-4A596C6E7521Q35776618-A76593F7-EFDB-4AC7-8E7B-5D706A74D836Q36338071-E1E1CB9F-82AF-4E48-97F2-2AFEAA56787DQ36415245-B8909FB4-C2C5-444A-8D9B-716F7AC86A49Q36492904-FA6A0016-51A1-434A-A69E-963E5B6B6AD7Q36790267-DA37E22C-88EC-42A2-AB64-8B44159ADD87Q36867184-D83F9B48-5800-4F6C-A5D4-F87EE3C055CEQ37170464-FA851E5E-FCDA-491E-B48B-3DED62D09005Q37222656-F03EAF3F-3677-467F-87F2-015E19A08A6CQ38087383-92B4B72F-5B1C-40A5-A1A2-0ABCD6CD0BBFQ38817761-E4D95B9A-9E45-4324-A038-5285DAEA9D4FQ38829760-9EA0ED77-B330-4333-9F98-61E863CF5127Q38937414-E9CF50F0-326D-4783-859F-9ED623982925Q40287159-E473CBBC-DD5A-47A9-B6D9-367362928B4EQ41089511-85B538C2-AC58-44D6-8146-36B05D64FEE6Q41531207-FD3A1775-69BF-436F-8807-9AFCF478D07EQ42114304-60B74BE1-9733-4B12-A86C-74EBEC9442E1Q42115684-526086D5-7FA3-4871-A619-EDDDEDCD3EFBQ42746435-1D54DAA5-ACAF-4ECA-8614-978426F39EEAQ46248790-BB703DE6-B678-4BEA-AF36-77197545E163Q47390287-59899E3C-0F3E-4824-80CA-2D0C3EDC2D2FQ47430766-CE60032F-BF96-4EF7-9D01-551066FF729BQ49588339-00B9B98B-BBF2-4E7F-B986-C2787F948BBFQ50423780-4AB4680C-4803-451C-8406-98157D08C916
P2860
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
S1P, dihydro-S1P and C24:1-cer ...... nce of ischemic heart disease.
@ast
S1P, dihydro-S1P and C24:1-cer ...... nce of ischemic heart disease.
@en
type
label
S1P, dihydro-S1P and C24:1-cer ...... nce of ischemic heart disease.
@ast
S1P, dihydro-S1P and C24:1-cer ...... nce of ischemic heart disease.
@en
prefLabel
S1P, dihydro-S1P and C24:1-cer ...... nce of ischemic heart disease.
@ast
S1P, dihydro-S1P and C24:1-cer ...... nce of ischemic heart disease.
@en
P2093
P2860
P356
P1476
S1P, dihydro-S1P and C24:1-cer ...... nce of ischemic heart disease.
@en
P2093
Alan T Remaley
Amar A Sethi
Brent A Wilkerson
Jeremy L Barth
Katherine S Nicholas
Kelley M Argraves
Patrick J Gazzolo
Sharon D Yeatts
W Scott Argraves
P2860
P2888
P356
10.1186/1476-511X-10-70
P577
2011-05-09T00:00:00Z